Far-Ultraviolet-C (far-UVC) 222 nm was introduced during the Covid-19 pandemic to disinfect the airborne pathogens, particularly SARS-CoV-2. Although far-UVC 222 nm has shown promising results in surface disinfection, its efficacy in air disinfection remains uncertain due to additional variables in air. This study investigated the efficacy of far-UVC 222 nm UVGI in air disinfection experimentally, using total plate count, and input the measured far-UVC intensity into the computational fluid dynamic model to predict infection risk using the Wells-Riley model. Experimental results indicated that after 1 h of far-UVC irradiation, an equivalent far-UVC dosage of 21.31 J/m2, airborne bacteria concentration was reduced by 44.4 %–74.1 %, while airborne fungal concentration showed a marginal reduction. In a recirculating air-conditioned room, a 20 W far-UVC fixture installation, referred to as Case 1, demonstrated the highest available dosage of 7.66 % difference compared to Case 2. The use of far-UVC in Case 1 can reduce the risk of infection for the influenza H1N1, SARS-CoV-2, and Mycobacterium tuberculosis by 54.48 %, 60.06 %, and 83.73 %, respectively. The study suggests installing far-UVC near the recirculating air-conditioner supply air jet and away from surrounding walls for optimum effectiveness. These results provide recommendations for alternatives to upper-room UVGI, offering a viable option for continuous room air and surface disinfection.